Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic AsthmaAlvares, L ; Kumar, P ; Muthukumar, M ; Lesperance, S ; Katsaounou, PValue in health, 2017-10, Vol.20 (9), p.A652-A653 [Periódico revisado por pares]Lawrenceville: Elsevier Science LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression FracturesOlafsson, G ; Mesterton, J ; Berenson, J.R ; Vrionis, F ; Alvares, LValue in health, 2012-11, Vol.15 (7), p.A406-A406 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysisStam, W ; Alvares, L ; Birinyi-strachan, L ; Maetzel, AValue in health, 2011, Vol.14 (7), p.A245-A245 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
PMS78 Measurement Strategy for Kyphosis: New Evidence from Patients and PhysiciansBayliss, M.S ; Miltenburger, C ; Van de Maele, C ; Alvares, L ; Bujanover, SValue in health, 2011, Vol.14 (7), p.A317-A317 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
PRS18 - Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in JapanMuthukumar, M ; Kozawa, M ; Alvares, L ; Milligan, K ; Igarashi, AValue in health, 2018-09, Vol.21, p.S104-S105 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma PatientsKaur, H ; Dongare, S ; Lijie, W ; Alvares, LValue in health, 2018-09, Vol.21, p.S104 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
PRS17 - Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma PatientsKaur, H ; Dongare, S ; Lijie, W ; Alvares, LValue in health, 2018-09, Vol.21, p.S104-S104 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
8 |
Material Type: Artigo
|
Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in JapanMuthukumar, M ; Kozawa, M ; Alvares, L ; Milligan, K ; Igarashi, AValue in health, 2018-09, Vol.21, p.S104-S105 [Periódico revisado por pares]Texto completo disponível |
|
9 |
Material Type: Artigo
|
PRS74 - Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic AsthmaAlvares, L ; Kumar, P ; Muthukumar, M ; Lesperance, S ; Katsaounou, PValue in health, 2017-10, Vol.20 (9), p.A652-A653 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
PRS10 - POPULATION HEALTH IMPACT OF OMALIZUMAB OVER 11 YEARS OF USE IN IRELAND IN MODERATE TO SEVERE ALLERGIC ASTHMACorless, S. ; Alvares, L. ; Kumar, P. ; Muthukumar, M. ; Lesperance, S. ; Katsaounou, P.Value in health, 2018-10, Vol.21, p.S405-S405 [Periódico revisado por pares]Elsevier IncTexto completo disponível |